Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 2
2019 2
2020 5
2021 2
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Frailty and relapse activity in multiple sclerosis: A longitudinal observation.
Baione V, Canevelli M, Belvisi D, Buscarinu MC, Bellucci G, Fantozzi R, Nicoletti CG, Malatuni G, Cortese A, De Giglio L, Tartaglia M, Ferrazzano G, Malimpensa L, Leodori G, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Baione V, et al. Among authors: tartaglia m. Mult Scler Relat Disord. 2023 Apr;72:104603. doi: 10.1016/j.msard.2023.104603. Epub 2023 Mar 5. Mult Scler Relat Disord. 2023. PMID: 36905818
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
Dominelli F, Zingaropoli MA, Tartaglia M, Tortellini E, Guardiani M, Perri V, Pasculli P, Ciccone F, Malimpensa L, Baione V, Napoli A, Gaeta A, Lichtner M, Conte A, Mastroianni CM, Ciardi MR. Dominelli F, et al. Among authors: tartaglia m. Front Immunol. 2022 Dec 1;13:1050183. doi: 10.3389/fimmu.2022.1050183. eCollection 2022. Front Immunol. 2022. PMID: 36532061 Free PMC article.
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study.
Zingaropoli MA, Pasculli P, Iannetta M, Perri V, Tartaglia M, Crisafulli SG, Merluzzo C, Baione V, Mazzochi L, Taglietti A, Pauri F, Frontoni M, Altieri M, Gaeta A, Antonelli G, Conte A, Mastroianni CM, Ciardi MR. Zingaropoli MA, et al. Among authors: tartaglia m. Mult Scler J Exp Transl Clin. 2022 Jan 4;8(1):20552173211065731. doi: 10.1177/20552173211065731. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35003758 Free PMC article.
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis.
Baione V, Belvisi D, Cortese A, Cetta I, Tartaglia M, Millefiorini E, Berardelli A, Conte A. Baione V, et al. Among authors: tartaglia m. Mult Scler Relat Disord. 2020 Feb;38:101494. doi: 10.1016/j.msard.2019.101494. Epub 2019 Nov 5. Mult Scler Relat Disord. 2020. PMID: 31715502
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R, Creta A, Cecchi G, Cola G, Nicoletti CG, Cortese A, De Giglio L, Tartaglia M, Crisafulli SG, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Belvisi D, et al. Among authors: tartaglia m. Mult Scler. 2021 Oct;27(12):1939-1947. doi: 10.1177/1352458520987541. Epub 2021 Feb 10. Mult Scler. 2021. PMID: 33565913
20 results